JME - Journal of Medical Economics

jme

Monthly readership: 5,800*

Register now for your free trial of JME

* Atypon usage statistics and estimated print views

jme Currently JME has 24 issues available,
published between 1998 and 2010...
Learn More »

JME's high-quality author service...
Testimonials »

Podcast

Comparison of utilization, cost, adherence, and hypoglycemia in patients with type 2 diabetes initiating rapid-acting insulin analog with prefilled pen versus vial/syringe
Lauren J. Lee, Qian Li, Matthew W. Reynolds, Manjiri D. Pawaskar, Sheila M. Corrigan

Journal of Medical Economics, Vol. 14, No. 1, 2011 p75

View more JME podcasts

More »

EarlyOnline

Derivation of severity index for rheumatoid arthritis and its association with healthcare outcomes

Thu, 26 Apr 2012 09:23:14 GMTalerts@informahealthcare.com (O. Baser et al)

Resource Utilization and Cost of Heart Failure associated with Reduced Ejection Fraction in Swedish Patients

Thu, 17 May 2012 12:02:16 GMTalerts@informahealthcare.com (Jan St�lhammar et al)

The impact of non-severe hypoglycemic events on daytime function and diabetes management among adults with type 1 and type 2 diabetes

Wed, 18 Apr 2012 08:02:33 GMTalerts@informahealthcare.com (Meryl Brod et al)

Resource utilization and costs following hospitalization of patients with chronic heart failure in the US

Tue, 15 May 2012 14:58:34 GMTalerts@informahealthcare.com (Caroline Korves et al)

Editor's Choice

Cost-effectiveness of prasugrel in a US managed care population

Real-life treatment patterns, compliance, persistence, and medication costs in patients with hypertension in Germany

More »

Most Read

Willingness-to-pay for benefits associated with basal insulin treatment of type 2 diabetes

Cost-effectiveness of adalimumab, etanercept, and tocilizumab as first-line treatments for moderate-to-severe rheumatoid arthritis

Adalimumab, etanercept, and infliximab utilization patterns and drug costs among rheumatoid arthritis patients

Cost analysis: treatment of chemotherapy-induced anemia with erythropoiesis-stimulating agents in five European countries

More »

Featured Articles

Direct and indirect costs of patients treated with extended-release oxymorphone HCl or controlled-release oxycodone HCl
Noam Y. Kirson, Alan G. White, Howard G. Birnbaum, Matt Schiller, Tracy Waldman, Kirsten Peterson, Rami H. Ben-Joseph, Todd Berner, Kent H. Summers

e-Content Alerts

Sign up for our e-Content Alerts and never miss the publication of an article from JME

OpenJME

Access all our free online content

Priority Publication Services

priority publication services

Publish your manuscript online in as little as 10 weeks with our RapidTrack option. Learn more...

Follow JME on

Stay up-to-date with JME by following us on twitter

Feedback

We would love to know what you think of the redesigned journal and website, what you think of our content and what we can improve.